Macquarie picks the best ASX shares to buy for the August reporting season

With more than half the population in lockdown, this reporting season is getting trickier to navigate.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The rolling COVID-19 lockdowns to hit our major cities will leave a mark on next month's reporting season, but a top broker believes these ASX shares will outperform.

The Australian economy is likely to contract in the September quarter. This is threatening to derail the ASX's best earnings upgrade cycle in decades.

Against this backdrop with more than half of the country's population living in lockdown, the analysts at Macquarie Group Ltd (ASX: MQG) highlighted several ASX shares to buy.

A stopwatch ticking close to the 12 where the words on the face say 'Time to Buy'.

Image source: Getty Images

ASX earnings growth under a COVID cloud

"Australia's run of positive EPS [earnings per share] revisions – the best in decades – is into its 11th month," said Macquarie.

"The key drivers were banks and resources; but both are cyclicals, and the cycle is slowing. Results for 2H21 should beat expectations, but this makes for a tougher comp for FY22."

Best ASX shares to buy for the reporting season

In this regard, the broker reckons the best ASX shares to buy ahead of the August reporting season are the COVID losers.

This is despite this group taking another beating from the current string of lockdowns to hit New South Wales, Victoria and South Australia.

Talk about a contrarian trade! ASX shares that are suffering under lockdowns are likely to provide dour outlooks. No one knows how long these lockdowns could go on for.

How ASX COVID losers could turn into winners

But Macquarie isn't fussed. It pointed out that the COVID hit to profits isn't expected to be as significant as it was in 2020.

"A miss on results could also cause a sell-off in these stocks, but we would buy the dips in re-opening plays, as they offer growth within a slowing cycle," said the broker.

Macquarie's best buy ideas for ASX shares favour defensives, growth and capital returns.

Defensive ASX shares to buy now

The defensive ASX shares that it likes includes the Amcor CDI (ASX: AMC) share price and Brambles Limited (ASX: BXB) share price, just to name a few.

Among the growth shares, it rates the Afterpay Ltd (ASX: APT) share price a buy even as expert opinion is dividend on its outlook.

Increasing competition and high valuation have taken the gloss out of the Buy Now, Pay Later (BNPL) posterchild.

Other ASX growth stocks on Macquarie's buy list include the Charter Hall Group (ASX: CHC) share price, Resmed CDI (ASX: RMD) share price and SEEK Limited (ASX: SEK) share price.

Capital return hopefuls to add to wishlist

The ASX shares that are likely to deliver capital returns that the broker rates a "buy" include three iron ore miners. These are the BHP Group Ltd (ASX: BHP) share price, Fortescue Metals Group Limited (ASX: FMG) share price and Deterra Royalties Ltd (ASX: DRR) share price.

Outside of these ASX miners, Macquarie also added the Ampol Ltd (ASX: ALD) share price as a capital return "buy" idea.

Motley Fool contributor Brendon Lau owns shares of BHP Billiton Limited, Deterra Royalties Limited, and Fortescue Metals Group Limited. Connect with me on Twitter @brenlau.

The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of and has recommended AFTERPAY T FPO. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has recommended ResMed. The Motley Fool Australia owns shares of and has recommended AFTERPAY T FPO and Amcor Limited. The Motley Fool Australia has recommended ResMed Inc. and SEEK Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Broker Notes

A woman leans forward with her hand behind her ear, as if trying to hear information.
Broker Notes

Down 60%, are Cochlear shares now a bargain buy?

A leading analyst provides his outlook for Cochlear’s beaten-down shares.

Read more »

A businessman hugs his computer and smiles.
Broker Notes

Why this ASX stock is a 'compelling value play'

Value investors might want to check out this share that Bell Potter is bullish on.

Read more »

Man holding a calculator with Australian dollar notes, symbolising dividends.
Broker Notes

Should I buy Rio Tinto shares for passive income?

A leading analyst provides his outlook for Rio Tinto shares and dividends.

Read more »

Woman with her fingers crossed and eyes shut.
Broker Notes

4 ASX shares upgraded by brokers this week

Brokers have new confidence in TPG Telecom, Deep Yellow, and other stocks this week.

Read more »

Three adorable children sit side by side at a table wearing upturned colanders on their heads fixed with shining light bulbs as they smile at the camera.
Broker Notes

Buy, hold, sell: Nick Scali, Nyrada, Wesfarmers shares

Experts reveal their ratings on three ASX shares in the retail and biotech segments. 

Read more »

A young woman smiling and looking happy, indicating a positive share price movement on the ASX market.
Broker Notes

8 ASX 200 shares with renewed buy ratings this week

Brokers retained a positive view on CSL, GQG Partners, ANZ, and other shares this week. 

Read more »

A woman with short brown hair and wearing a yellow top looks at the camera with a puzzled and shocked look on her face.
Broker Notes

5 ASX 200 shares downgraded by the experts this week

Brokers have lowered their ratings on Megaport, REA, and other stocks this week. 

Read more »

Time to sell written on a clock.
Broker Notes

Sell alert! Why this expert is calling time on NAB and Westpac shares

A leading analyst foresees looming storm clouds over NAB and Westpac shares.

Read more »